
Overview
Joseph Swanson is a partner in the Corporate Department at Paul Hastings and is a member of the firm's Mergers & Acquisitions practice. He is based in the firm's Orange County office.
Joseph's practice focuses on mergers and acquisitions, including stock acquisitions, asset acquisitions, joint ventures, cross-border acquisitions and other business combination transactions, as well as venture-capital investments and other equity-financing transactions. He has considerable experience representing both public and private entities, including SPACs, private equity funds and private equity-backed companies across a wide array of industries, including technology, fintech, life sciences, software, healthcare, professional services, retail, and food and beverage, among others.
Education
- George Washington University Law School (with honors), 2006
- University of Nevada, 1997
Representations
- Acadia Pharmaceuticals in its acquisition of CerSci Therapeutics, a clinical-stage biotechnology company with worldwide rights to a portfolio of novel compounds for neurological conditions.
- e-Molecules, Inc., an e-procurement platform for high-value chemicals and bioreagents used in drug discovery, in its sale to Avista Capital Partners, a private equity firm focused on healthcare.
- Acadia Pharmaceuticals in its acquisition of Levo Therapeutics, Inc., a clinical-stage biotechnology company focused on the treatment of Prader-Willi Syndrome.
- GI Partners, a private equity-investment firm, in its simultaneous acquisition and combination of Cord Blood Registry, the world’s largest stem-cell collection and storage company, and California Cryobank, the world’s premier donor sperm and egg bank.
- Moody's, in its acquisition of RMS, a leading global provider of climate and natural disaster risk modeling and analytics, for approximately $2 billion from Daily Mail and General Trust plc.
- Banc of California, in its acquisition of the e-commerce payments platform and technology of Global Payroll Gateway, Inc. and Deepstack Technologies, LLC for approximately $24 million.
- Acorns, in its acquisition of Harvest, a startup focused on consumer debt-reduction solutions.
- Moody's, in its acquisition of PassFort Limited, a U.K.-based workflow platform for identity verification, customer onboarding and risk analysis.
- Moody's, in its acquisition of 360kompany AG, an Austria-based platform for audit-proof business verification and KYC operating a network of primary-source information on more than 115 million companies across 200 jurisdictions.
- Mitek Systems, in acquisition of HooYu Limited, a U.K.-based company specializing in KYC and related customer-onboarding technology, for $128 million.
- AssetMark Financial Holdings, Inc., in its acquisition of Adhesion Wealth, a leading provider of wealth-management technology solutions to registered-investment advisers (RIAs), RIA enterprises and asset managers.
- Moody's, in its acquisition of Cortera, Inc., a provider of North American credit data and workflow solutions.
- Vista Dental, a portfolio company of private equity firm Inverness Graham Investments, in its acquisition of Apex Dental Materials, a branded manufacturer of restorative dental materials including adhesives, primers, composites and cements.
- Standard Homeopathic Company, maker of the Hyland's brand of homeopathic products, in its acquisition of a private equity firm.
- Moody's, in its acquisition of Catylist, Inc., a provider of commercial real estate solutions to brokers.
- Endeavour Capital, in its sale of grocery chains Bristol Farms, Lazy Acres Market and Metropolitan Market, to e-Mart, South Korea's largest retailer.
- ForeFlight, a Boeing Company, in its acquisition of CloudAhoy, a provider of post-flight debriefing, analytics and flight operations quality assurance software products.
- GE, in its acquisition of Innoveering, LLC, a company specializing in advanced hypersonic-propulsion technology.
- Acorns, in its acquisition of GoHenry, a leading provider of financial applications and education for children and their families.
News
- Paul Hastings Advises Semperis on Its Acquisition of MightyID - February 5th, 2026
- Paul Hastings Advises FACT II Acquisition Corp. on $320 Million Business Combination With Precision Aerospace & Defense Group - December 2nd, 2025
- Paul Hastings Advises Pennant’s $146.5 Million Purchase of Certain Operations From UnitedHealth Group - October 7th, 2025
- Paul Hastings Advises CWT Us in $540 Million Acquisition by Global Business Travel Group - September 5th, 2025
- Paul Hastings Advises Cashet Card in Sale of Cashet Entertainment to Entertainment Partners - June 5th, 2025
- Paul Hastings Advises Renatus Tactical Acquisition Corp I on Its $210 Million IPO - May 16th, 2025
- Paul Hastings Advises Amentum in Agreement to Divest Rapid Solutions Product Business to Lockheed Martin - April 23rd, 2025
- Paul Hastings Advises Marblegate Capital Corp. and Marblegate Acquisition Corp. on Business Combination With DePalma Companies - April 10th, 2025
- Paul Hastings Advised Fisher Investments in $3 Billion Strategic Investment by Advent International and ADIA - January 7th, 2025
- Paul Hastings Advised FACT II Acquisition Corp. on the Pricing of Its IPO - November 26th, 2024
- Paul Hastings Advised CAI on the Acquisition of Parsable, Inc. - September 27th, 2024
- Paul Hastings Advised CWT US, LLC in Agreement to be Acquired by Global Business Travel Group in $570 Million Transaction - April 11th, 2024
- Paul Hastings Representing Seaport Global Acquisition II Corp. in Business Combination with American Battery Materials, Inc. - June 8th, 2023
- Paul Hastings Advised Nuveen in Acquisition from Omni Holdings - May 10th, 2023
- Paul Hastings Advises Banc of California in Acquisition of Deepstack Technologies - September 16th, 2022